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ABSTRACT 
Aesculus hippocastanum is highly regarded for their medicinal properties in the indigenous system of medicine. The objectives of the present study include the 
validation of Aesculus hippocastanum extract. Authenticated extract of seeds of the plant was collected and the method was developed for the validation. In 
this the extract was subjected to check the  Accuracy, Precision, Linearity and  Specificity. For the validation UV spectrophotometer was used. The proposed 
UV validation method for the extract is accurate, linear, precise, linear, specific and within the range. Further isolation and in-vitro studies are needed. 
Keywords: Aesculus hippocastanum, Accuracy, Precision, Linearity, Specificity. 
 
INTRODUCTION 
Medicinal  plants  have  been  a  major  source  of  therapeutic 
agents  or  alleviation  or  cure  human  diseases  since  from 
longer time. According to an all India ethno biological survey 
carried  out  by  the  Ministry  of  Environment  &  Forests, 
Government of India, There are over 8000 species of plants 
being being used by the people of India.
1. Not many of Indian 
herbal product are available in standardization form, which is 
the  minimum requirement  for  introducing  a  product  in  the 
western market. So effort should be made to promote safety 
quality,  integrity,  standardization,  validation  of  standard 
method  in  written  document  form  and  authenticity  of  the 
herbal  products  to  match  the  requirements  of  WHO 
guidelines,  which  would  inevitably  help  in  raising  the 
acceptance of Indian plant based products globally. New  a 
days R&D thrust in the pharmaceutical sector is focused on 
validation  of  standard  method.      Aesculus  hippocastanum 
belongs  to  family  Hippocastanaceae  also  called  as  Horse 
Chest nut
2, indigenous to western asia, spreading to Europe 
and  now  widely  cultivated  around  the  world  as  an 
ornamental
2.  The  major  phytoconstituents  of  drug  under 
study are saponins. Plant material containing saponins have 
long been used in many parts of the world for their detergent 
properties. The major phytoconstisuents present in Aesculus  
hippocastanum  are,  Saponins  of    -amyrin type  known  as 
aescin
3and  -aescin. The other phytoconstituents present are 
Flavonoids, tannins, tannis, and oligosaccharides
4. Validation 
is  a  concept  that  has  been  evolving  continuously,  its  first 
formal  appearance  is  in  the  United  States  in  1978
5.  The 
validation  of  an  analytical  procedure  is  the      process  of 
confirming that the analytical procedure employed for a test 
of  pharmaceutics  is  suitable  for  its  intended  use.  In  other 
word, the  validation  of  an analytical  procedure  requires  to 
demonstrate  scientifically  that  risks  indecision  by  testing 
caused by errors from analytical steps are acceptably small
6. 
Validation  is  a  basic  requirement  to  ensure  quality  and 
reliability of the results for all analytical applications
7. There 
are  two  important  reasons  for  validating  assays  in  the 
pharmaceutical  industry.  The  first,  and  by  for  the  most 
important, is that assay validation is an integral part of the 
quality  –  control  system.  The  second  is  that  current  good 
manufacturing practice regulation requires assay validation
8. 
Benefits of Method validation
9 
A  fully  validated  process  may  require  less  in  –  process 
control and end product testing.It deepens the understanding 
of processes, decrease the risks of processing problems, and 
thus assure the smooth running of the process. 
Steps in method validation
10 
Develop a validation protocol or operation procedure for the 
validation. 
Define the application, purpose and scope of the method. 
Define the performance parameter and acceptance criteria. 
Define validation experiments. 
Verify relevant performance characteristic of equipment. 
Quality materials (for e.g. standard and reagents). 
Perform pre – validation experiments. 
Adjust  method  parameter  or  /  and  acceptance  criteria  if 
necessary. 
Perform full internal and external validation equipments. 
Developed SOP for executing the method in the routines. 
Define criteria for revalidation. 
Define type and frequency of system for suitability test and / 
or analytical quality controa (AQC) for the routine. 
Document validation experiment and result in the validation 
report. 
The  international  Conference  on  Harmonization  (ICH)  of 
Technical  Requirements  for  the  Registration  of 
Pharmaceuticals  for  Human  Use
11.  Has  developed  a 
consensus text on the validation of analytical procedures. The 
document  includes  definitions  for  eight  validation 
characteristics. An extension with more detailed methodology 
is  in preparation and nearly  completed
12.The  United  States 
Food  and  Drug  Administration  (US  FDA)  has  proposed 
guidelines  on  submitting  samples  and  analytical  data  for 
methods  validation
13-15.  The  Untied  States  Pharmacopoeia 
(USP)  has  published  specific  guidelines  for  method 
validation for compound evaluation
16.To validate biological 
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industry  uses  methodology  published  in  the  literature.
17,  18 
The  most  comprehensive  document  was  published  as  the 
‘Conference  Report  of  the  Washington  Conference  on 
Analytical  Methods  Validation  :  Bioavailability, 
Bioequivalence  and  Pharmacokinetic  Studies  held  in  1990 
(sponsored by the American Association of Pharmaceutical 
Scientists, the AOAC and the US FDA, among others)
18. The 
report present guiding principles for validation of studies in 
both human and animal subjects that may be referred to in 
developing future formal guidelines. 
MATERIALS AND METHODS 
Instruments and Materials  Instrument used was Shimadzu 
UV  –  1700  UV  visible  spectrophotometer.  The  standard 
extract  of  Aesculus  hippocastanum  was  collected  from 
Pharmed medicare Banglore. The sample used was extract of 
Aesculus hippocastanum. All the apparatus, instruments and 
glass wares were calibrated before starting of experimental 
work. 
Preparation of standard  Standard solution of concentration 
1 mg/ ml was prepared with water in 100 ml volumetric flask 
using standard extract of Aesculus hippocastanum. From this 
stock, throught a series of dilutions, working standards were 
prepared  of  concentration  30,  40,  50,  60,  70,  80,  90,  100 
  with  water  methanol  in  10  ml  volumetric  flasks. 
These  dilutions  were  scanned  on  a  UV  spectrophotometer 
between  the  wavelength  200-400 nm.  Absorbance  maxima 
wavelength for extract of Aesculus hippocastanum selected at 
265 nm for the current study. 
Preparation of Sample Accurately weighed 10 mg extract of 
Aesculus hippocastanum was taken in 50 ml volumetric flask 
with  sufficient  quantity  of  water  and  sonicated  for  5  min. 
Volume  was  made  up  to  50  ml  with  water.  The  resulting 
solution was then filtered. From the filtered stock 1.5, 2, 2.5, 
3, 3.5, 4, 4.5, 5 ml  of solution was taken in five separate 10 
ml volumetric flasks and volume is made up to 10 ml with 
water.  The  absorbance  of  sample  was  recorded  at  265nm 
using water as a reference. 
Validation of the method  
Validation of an analytical method is the process to establish 
by laboratory studies that the performance characteristic of 
the method meets the requirements for the intended analytical 
application.  Performance  characteristics  are  expressed  in 
terms of analytical parameters. 
Design of experiment 
Typical analytical parameters used in assay validation are : 
a)  Linearity / Beer’s Law Range 
b)  LOQ (Limit of Quantification) and Standard calibration 
curve 
c)  Precision 
d)  Sensitivity 
e)  Accuracy 
RESULTS AND DISCUSSION 
Development of method 
The  UV  spectrophotometric  method  for  estimation  of 
Aesculus hippocastanum extract has been developed. As the 
extract is purely soluble in water, it is selected as the best 
suitable solvent for estimation. 
The wavelength maxima ( ) is the peak maxima in the 
serial  dilutions  of  working  standards  at  the  constant 
wavelength. For estimating Aesculus hippocastanum extract 
is selected at 265 nm (fig 1). 
Determination of 
0 (1 % l cm) of Aesculus hippocastanum 
extract at selected wavelength : 
The    absorbance  for  the  standard  dilutions  of  Aesculus 
hippocastanum extract was measured at 265 nm. From the 
absorbance  readings  the  absorptivity  ( 
0    )  of  Aesculus 
hippocastanum extract was calculated with equation.    
0 = 
A/C .... Eqn. 1, 
Where A is absorbance and C is concentration in g/ 100 ml. 
The absorptivity of Aesculus hippocastanum extract at 265 
nm was 16.39 mole
-1 cm
-1 shown in table no 1. 
Development  of  Equation  for  estimating  Aesculus 
hippocastanum extract  
The equation was developed for calculating the concentration 
of extract. 
Cxx = A/ 
0 .... Eqn.2 
Where, A is absorbance of sample at 265nm, 
0 is absorptivity 
of  Aesculus  hippocastanum  extract  at  265  nm.  Cxx  is 
concentration  of  extract  in  g/  100  ml  respectively.  The 
equation 2 was modified for calculating the concentration of 
Aesculus hippocastanum extract in sample as cxx = A/ 16.39. 
The assay calculation was shown in table no 2. 
Validation of method 
Linearity / Beer’s Law Range  
Determination  of  Linearity  range  for  Aesculus 
hippocastanum extract shown in table no 3. 
Linearity report of Aesculus hippocastanum extract shown 
in table no 4 
Beer’s law concentration range is shown in fig 2 
Limit of detection (LOD) 
Report : The Limit of detection for Aesculus hippocastanum 
extract  was  found  to  be  0.5  mcg/ml  and  Limit  of 
Quantification was found to be l mdg/ml shown in table no 5. 
Precision 
Precision of the instrument 
Instrument  precision  Reports  of  Aesculus  hippocastanum 
extract is shown in talbe no 6 
Report 
From  the  precision  data  of  the  instrument,  the  RSD  for 
Aesculus  hippocastanum  extract  was  1.823704%  which  is 
well  within the  acceptance  criteria  of  not  more  then  2% . 
Hence  the  precision  of  the  instrument  is  found  to  be 
satisfactory. 
Precision of the method : 
Method  precision  Report  of  Aesculus  hippocastanum 
extract 
Report 
From the precision data of the method, the RSD for Aesculus 
hippocastanum extract was 0.1136% and which is within the 
acceptance criteria of not more then 2% . Hence the precision 
of the method is found to be satisfactory. Shown in table no 7 
Sensitivity 
Determination  of  sensitivity  of  Aesculus  hippocastanum 
extract 
Report 
From the sensitivity data, sandell’s sensitivity for Aesculus 
hippocastanum extract was found 0.061317. The results were 
in  agreement  as the  sensitivity  was  found  to  be  within he 
permissible limits. Shown in table no 8. 
Accurany 
Determination of accuracy 
In  case  if  assay  of  a  drug  substance  accuracy  may  be 
determined  by  application  of  the  analytical  method  to  an 
analyte  of  known  purity  (e.g.  reference  standard)  or  by Biradar sanjivkumar et al. IRJP 2012, 3 (7) 
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comparison  of  the  results  of  the  method  with  those  of  a 
second well characterized method, the accuracy of which has 
been  stated  or  defined.  Accuracy  is  calculated  as  the 
percentage  of  recovery  by  the  assay  of  the  known  added 
amount of analyte in the sample, or as the difference between 
the  mean  and  the  accepted  true  value,  together  with 
confidence intervals. 
The ICH documents recommended that accuracy should be 
assessed  suing  a  minimum  of  nine  determination  over  a 
minimum  of  three  concentrations  levels,  covering  the 
specified range (i.e., three concentrations and three replicates 
of each concentration). 
Recovery study data of Aesculus hippocastanum extract 
The recovery calculation method is shown in table no 9 
Recovery report for Aesculus hippocastanum extract 
From  the  recovery  data,  the  recovery  for  Aesculus 
hippocastanum  extract  was  found  in  the range  of  94.56  to 
102.5%. The results  were  in  agreement  as the  % recovery 
was found to be within he permissible limits of 92 – 108%. 
Shown in table no 10. 
Optical  Characteristics  of  Aesculus  hippocastanum 
extract- Shown in table no 11. 
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Fig 1 
 
 
Fig 2 Beer’s law concentration range 
 
 
Table 1: Absorptive of Aesculus hippocastanum extract 
Sl 
No. 
Conc. Of Working 
Standard 
(  
A  A mole
-1cm
-1 
1  30  0.045  15 
2  40  0.063  15.75 
3  50  0.078  15.6 
4  60  0.108  18 
5  70  0.119  17 
6  80  0.135  16.875 
7  90  0.148  16.444 
8  100  0.165  16.5 
    Avg  16.39 
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Table 2: Assay of Sample Aesculus hippocastanum extract 
Sl.No  Vol. of Stock 
Taken (ml)  A  Cxx  Theoretical 
Conc. 
% Practical 
Conc. 
1  1.5  0.049  29.896  30  99.65426 
2  2  0.061  37.217  40  93.04454 
3  2.5  0.079  48.200  50  96.40024 
4  3  0.104  63.453  60  105.7555 
5  3.5  0.121  73.825  70  105.465 
6  4  0.141  86.028  80  107.5351 
7  4.5  0.155  94.569  90  105.0776 
8  5  0.169  103.11  100  103.1117 
 
Table 3 : Linearity data for Aesculus hippocastanum extract 
Sl. 
No 
Volume of Aesculus hippocastanum 
extract stock solution (ml) 
 
Final Volume 
(ml) 
Concentration 
 
Absorbance* 
1  0.3  10  30  0.045 
2  0.4  10  40  0.063 
3  0.5  10  50  0.078 
4  0.6  10  60  0.108 
5  0.7  10  70  0.119 
6  0.8  10  80  0.135 
7  0.9  10  90  0.148 
8  1.0  10  100  0.165 
9  2.0  10  200  0.328 
10  3.0  10  300  0.502 
11  4.0  10  400  0.651 
12  5.0  10  500  0.809 
*Average of six readings 
 
Table no 4 Linearity report 
Parameter  Result observed  Acceptance criteria 
Correlation co – efficient  0.9995  Not less than 0.99% 
Percentage curve fitting  99.95  Not less than 99.7% 
Regression Equation (Y)  0.0016x + 0.0025  - 
Slope (b)  0.0016x  - 
Intercept (a)  0.0025  - 
 
Table 5 : Limit of detection for Aesculus hippocastanum extract. 
Sl. 
No 
Dilution volumes From 
2
nd stock Solution (ml) 
Concentration 
meg / ml 
Absorbance 
1  2 ml  2  0.003 
2  1 ml  1  0.001 
3  0.5 ml  0.5  - 
 
Table 6 – Instrument precision report 
Parameters  Result observed  Acceptance criteria 
Relative standard deviation for the method  1.823704  Not more than 2% 
 
Table no 7 – Precision report of method. 
Parameters  Result observed  Acceptance criteria 
Relative standard deviation For the method  0.1136  Not more than 2% 
 
Table no 8 - Determination of sensitivity of Aesculus hippocastanum extract 
Sl.No 
Conc. 
(mcg / 100 ml)  Absorbance 
Sandell’s 
Sensitivity 
1  3000  0.045  0.066667 
2  4000  0.063  0.063492 
3  5000  0.078  0.064103 
4  6000  0.108  0.055556 
5  7000  0.119  0.058824 
6  8000  0.135  0.059259 
    Avg  0.061317 
 
Table no 9- Recovery study data of Aesculus hippocastanum extract 
Sl. 
No 
Std Aesulus 
hippocastanum 
extract 
Conc (A) 
 
Samp Aesculus 
hippocastanum 
extract 
Conc . (B) 
 
Total 
Conc. 
(A + B) 
 
Absorbanc
e 
Total Amount 
(A + B) 
 
Amount Of std. 
Recovered 
% Recovery 
Of standard 
1  10  20  30  0.048  29.28615  9.29615  97.62 
2  20  20  40  0.062  37.82794  17.82794  94.56 
3  30  20  50  0.084  51.25076  28.25076  93.35 
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Table no 10- Recovery report. 
Parameters 
% recovery of 
Aesculus hippocastanum extract  Acceptance criteria 
Level 1  97.62  92-108%. 
Level 1  94.56  92-108%. 
Level 1  93.35  92-108%. 
 
Table no 11 - Optical Characteristics of Aesculus hippocastanum extract 
Sl.No  Parameters  MS 
1  Beer’s Law limits (i g/ml)  30.500 
2  Wavelength maxima (nm)  265 
3 
Molar extinction coefficient 
(mole
-1 cm
-1 )  16.39 
4 
Sandell’s sensitivity 
(i g/cm
2 /0.001 absorbance units)  0.061317 
5 
Regression Equation (Y) 
Slope (b) 
Intercept (a) 
0..0016x + 0.0025 
0.0016x 
0.0025 
6  Coefficient of Variance  0.9995 
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